Nicholas J, Carraro M, Ontaneda D, et al. Comparative Effectiveness of Dimethyl Fumarate Versus Fingolimod and Teriflunomide on the Risk of Relapse in MS Patients Switching from First-Generation Platform Therapies in the US. AAN 2018, P1.374.
Vergoeding selumetinib (Koselugo) voor kinderen met neurofibromatose type 1
mei 2024